A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.
Clinical trial NCT03593785 · COMPLETED
Trial details
- NCT number
- NCT03593785
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2020-12-19
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.